The University of Chicago Header Logo

Theodore Karrison

Concepts (1164)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
37
2023
2438
2.320
Why?
Randomized Controlled Trials as Topic
10
2019
865
2.170
Why?
Clinical Trials, Phase II as Topic
9
2014
176
1.910
Why?
Research Design
9
2018
594
1.640
Why?
Survival Analysis
15
2022
1538
1.630
Why?
Antineoplastic Agents
28
2020
2360
1.390
Why?
Head and Neck Neoplasms
16
2022
1052
1.170
Why?
Clinical Trials, Phase III as Topic
4
2014
172
1.110
Why?
Humans
252
2023
86678
1.090
Why?
Prostatic Neoplasms
18
2023
1721
1.040
Why?
Lung Neoplasms
15
2023
2262
1.030
Why?
Aged, 80 and over
64
2023
6513
1.000
Why?
Neoplasm Recurrence, Local
14
2023
1313
0.990
Why?
Male
158
2023
40988
0.980
Why?
Neoplasms
23
2023
2898
0.970
Why?
Kidney Neoplasms
11
2022
621
0.960
Why?
Aged
99
2023
18423
0.940
Why?
Phenylurea Compounds
9
2014
114
0.940
Why?
Lymphoma, Large B-Cell, Diffuse
4
2023
151
0.910
Why?
Middle Aged
107
2023
25040
0.890
Why?
Female
159
2023
44550
0.880
Why?
Antibodies, Monoclonal, Humanized
14
2023
930
0.830
Why?
Carcinoma, Renal Cell
8
2022
426
0.800
Why?
Carcinoma, Squamous Cell
11
2022
1077
0.790
Why?
Adult
107
2022
25659
0.790
Why?
Carcinoma, Non-Small-Cell Lung
8
2021
1075
0.790
Why?
Protein Kinase Inhibitors
10
2022
589
0.770
Why?
Radiosurgery
5
2023
272
0.770
Why?
Treatment Outcome
47
2023
7998
0.710
Why?
Maximum Tolerated Dose
9
2019
270
0.710
Why?
Data Interpretation, Statistical
3
2018
297
0.710
Why?
Glucuronosyltransferase
6
2020
184
0.690
Why?
Ambulances
1
2018
15
0.660
Why?
Benzimidazoles
2
2017
140
0.650
Why?
Adenocarcinoma
12
2023
1169
0.650
Why?
Dose-Response Relationship, Drug
15
2020
1961
0.640
Why?
Leukemia, Myeloid, Acute
8
2020
763
0.600
Why?
Quinolines
2
2020
95
0.590
Why?
Prostatic Neoplasms, Castration-Resistant
4
2022
111
0.590
Why?
Quinazolines
7
2016
220
0.580
Why?
Air Pollution, Indoor
4
2017
63
0.580
Why?
Wounds and Injuries
2
2018
231
0.570
Why?
Stomach Neoplasms
6
2020
266
0.570
Why?
Hospital Mortality
1
2018
350
0.560
Why?
Disease-Free Survival
17
2023
1204
0.550
Why?
Pyridines
7
2015
310
0.530
Why?
Neoplasm Metastasis
13
2020
1056
0.530
Why?
Sirolimus
5
2022
170
0.530
Why?
Toxoplasmosis, Congenital
6
2015
42
0.520
Why?
Hematopoietic Stem Cell Transplantation
6
2023
878
0.520
Why?
Niacinamide
8
2014
116
0.510
Why?
Androgen Antagonists
7
2023
144
0.510
Why?
Health Services Accessibility
1
2018
394
0.510
Why?
Prospective Studies
33
2023
4214
0.510
Why?
Chicago
17
2020
1380
0.500
Why?
Camptothecin
6
2014
189
0.490
Why?
Esophageal Neoplasms
6
2020
322
0.480
Why?
Clinical Trials, Phase I as Topic
1
2015
155
0.480
Why?
Indoles
5
2015
318
0.470
Why?
Allergens
4
1998
179
0.470
Why?
Oropharyngeal Neoplasms
4
2022
118
0.470
Why?
Hodgkin Disease
6
2023
177
0.460
Why?
Multiple Myeloma
3
2023
307
0.460
Why?
Sulfonamides
5
2016
300
0.450
Why?
Time Factors
28
2020
5214
0.440
Why?
Papillomavirus Infections
4
2022
239
0.440
Why?
Aneurysm, Ruptured
2
2003
51
0.430
Why?
Pneumonectomy
2
2008
196
0.430
Why?
Cooking
3
2017
55
0.430
Why?
Cetuximab
4
2020
113
0.420
Why?
Antineoplastic Agents, Immunological
5
2020
185
0.420
Why?
Paclitaxel
7
2023
460
0.410
Why?
Vascular Endothelial Growth Factor Receptor-2
5
2015
81
0.410
Why?
Angiogenesis Inhibitors
5
2016
311
0.400
Why?
Breast Neoplasms
14
2020
2903
0.400
Why?
Chemoradiotherapy
5
2022
301
0.400
Why?
Androgens
5
2023
167
0.390
Why?
Sample Size
3
2007
130
0.390
Why?
Biomarkers, Tumor
11
2023
1464
0.390
Why?
Disease Progression
11
2023
1532
0.380
Why?
Survival Rate
14
2020
1864
0.380
Why?
Pleural Neoplasms
3
2018
188
0.380
Why?
Papillomaviridae
3
2022
153
0.380
Why?
Myelodysplastic Syndromes
4
2016
346
0.370
Why?
Vascular Endothelial Growth Factor A
7
2023
407
0.370
Why?
Radiation Oncology
2
2022
119
0.370
Why?
Carcinoma
7
2015
436
0.360
Why?
Pharmacogenomic Testing
2
2022
97
0.360
Why?
Neoplasms, Experimental
3
2019
269
0.360
Why?
Statistics, Nonparametric
6
2018
308
0.350
Why?
Adolescent
26
2022
8984
0.350
Why?
Mesothelioma
3
2018
311
0.350
Why?
Injury Severity Score
2
2021
111
0.350
Why?
Proportional Hazards Models
7
2018
860
0.350
Why?
Prognosis
22
2022
3680
0.350
Why?
Benzenesulfonates
4
2012
66
0.340
Why?
Drug Resistance, Neoplasm
5
2020
592
0.340
Why?
Fluorouracil
9
2020
556
0.340
Why?
Retrospective Studies
23
2023
8496
0.330
Why?
Antineoplastic Agents, Phytogenic
5
2014
276
0.330
Why?
Pharmacogenetics
5
2022
434
0.330
Why?
Anesthesiology
2
2022
157
0.330
Why?
Genotype
13
2022
1852
0.320
Why?
Gastrointestinal Neoplasms
2
2019
106
0.320
Why?
Toxoplasma
3
2015
108
0.320
Why?
Pregnancy
17
2017
2894
0.320
Why?
Pyrimidines
4
2016
370
0.320
Why?
Serum Albumin
1
2008
130
0.320
Why?
Prostate-Specific Antigen
11
2023
353
0.310
Why?
Endpoint Determination
1
2007
60
0.310
Why?
Abortion, Habitual
4
2001
33
0.300
Why?
Clinical Trials as Topic
7
2013
1169
0.300
Why?
Medical Oncology
2
2011
359
0.300
Why?
Proto-Oncogene Proteins c-met
4
2014
199
0.300
Why?
Combined Modality Therapy
11
2023
1686
0.300
Why?
Immunotherapy, Adoptive
4
2023
170
0.290
Why?
Colorectal Neoplasms
1
2014
938
0.290
Why?
Data Collection
5
2009
372
0.290
Why?
Ethanol
3
2017
249
0.290
Why?
Biomarkers
7
2022
1718
0.280
Why?
Chromosome Aberrations
4
2007
387
0.270
Why?
Polymorphism, Genetic
4
2019
819
0.270
Why?
Young Adult
12
2022
5980
0.270
Why?
Asthma
3
1998
955
0.270
Why?
Molecular Targeted Therapy
3
2020
266
0.270
Why?
Bayes Theorem
1
2007
361
0.270
Why?
Computer Simulation
2
2022
1078
0.260
Why?
ErbB Receptors
5
2020
485
0.260
Why?
Tumor Escape
2
2017
49
0.260
Why?
Drug Monitoring
3
2022
118
0.260
Why?
Leukemia
3
2006
320
0.260
Why?
Mastectomy, Radical
2
1999
10
0.260
Why?
Interleukin-2
3
2012
249
0.260
Why?
Oncogene Proteins, Viral
2
2020
34
0.250
Why?
Leucovorin
4
2020
218
0.250
Why?
Double-Blind Method
15
2012
1824
0.250
Why?
Quality of Life
8
2023
1585
0.250
Why?
Postoperative Complications
5
2019
2207
0.250
Why?
Ipilimumab
2
2021
58
0.250
Why?
Benzodioxoles
2
2015
16
0.250
Why?
Perioperative Care
3
2022
161
0.250
Why?
Pregnancy Outcome
7
2017
247
0.240
Why?
Anilides
2
2015
47
0.240
Why?
Cytokines
4
2023
778
0.240
Why?
Inflammation
2
2022
923
0.240
Why?
Pregnatrienes
1
2003
14
0.240
Why?
Early Growth Response Protein 1
2
2013
54
0.240
Why?
Thrombosis
2
2022
296
0.240
Why?
CD8-Positive T-Lymphocytes
3
2019
558
0.230
Why?
Lymphoma, Non-Hodgkin
6
2013
261
0.230
Why?
Metformin
2
2018
128
0.230
Why?
Prostate
3
2022
378
0.230
Why?
Kaplan-Meier Estimate
6
2018
861
0.230
Why?
Neoplasm Staging
12
2021
1939
0.230
Why?
Vasospasm, Intracranial
1
2003
36
0.230
Why?
C-Reactive Protein
2
2022
190
0.230
Why?
Haploinsufficiency
2
2013
62
0.230
Why?
Mastectomy
4
2015
243
0.230
Why?
Follow-Up Studies
15
2023
3642
0.230
Why?
Melanoma
2
2021
459
0.230
Why?
Aneurysm
1
2003
58
0.230
Why?
Chromosome Deletion
2
2013
229
0.220
Why?
Neuroprotective Agents
1
2003
94
0.220
Why?
Tumor Burden
5
2017
289
0.220
Why?
Intracranial Arteriosclerosis
1
2023
49
0.220
Why?
Dioxolanes
1
2002
8
0.220
Why?
Subarachnoid Hemorrhage
1
2003
137
0.220
Why?
Blood Pressure
4
2017
1144
0.220
Why?
Probability
2
2022
355
0.210
Why?
Models, Statistical
4
2012
575
0.210
Why?
Mitogen-Activated Protein Kinase Kinases
3
2013
101
0.210
Why?
Antibodies, Monoclonal
5
2021
1376
0.210
Why?
Tramadol
1
2022
14
0.210
Why?
Papillomavirus E7 Proteins
2
2020
31
0.210
Why?
Database Management Systems
1
2002
41
0.210
Why?
Cytosine
1
2002
127
0.200
Why?
Repressor Proteins
2
2020
403
0.200
Why?
Cockroaches
2
1998
10
0.200
Why?
Proto-Oncogene Proteins c-bcl-2
2
2019
189
0.200
Why?
Prostatectomy
2
2016
471
0.200
Why?
Neurosurgical Procedures
1
2003
213
0.200
Why?
Immunity
1
2022
136
0.200
Why?
Intracellular Signaling Peptides and Proteins
2
2016
379
0.200
Why?
Androstenes
2
2018
43
0.200
Why?
Cerebral Angiography
1
2002
196
0.200
Why?
Amitriptyline
1
2001
11
0.200
Why?
Drug-Related Side Effects and Adverse Reactions
2
2022
199
0.200
Why?
DNA, Viral
1
2022
265
0.190
Why?
Administration, Oral
11
2020
684
0.190
Why?
Capecitabine
2
2019
96
0.190
Why?
Household Articles
2
2017
15
0.190
Why?
Cisplatin
5
2023
612
0.190
Why?
Neoplasm Proteins
3
2016
532
0.190
Why?
Neoplasm Grading
2
2023
357
0.190
Why?
Academic Medical Centers
3
2019
380
0.190
Why?
Intracranial Aneurysm
1
2002
158
0.190
Why?
Immunoassay
2
2019
92
0.190
Why?
Graft vs Host Disease
1
2023
365
0.190
Why?
Cell-Free Nucleic Acids
1
2022
71
0.190
Why?
Neoplasm Transplantation
2
2019
391
0.190
Why?
Epothilones
2
2013
13
0.190
Why?
Mice
17
2023
11356
0.190
Why?
Vaginal Neoplasms
1
2020
83
0.190
Why?
Alleles
6
2013
1128
0.190
Why?
Naltrexone
4
2005
135
0.190
Why?
Carcinogens
1
2020
108
0.190
Why?
Gait
1
2001
80
0.190
Why?
Narcotic Antagonists
4
2005
154
0.190
Why?
Pyrrolidinones
1
2020
16
0.180
Why?
Antidepressive Agents
1
2001
106
0.180
Why?
Cell Cycle Proteins
3
2016
388
0.180
Why?
Anesthesia
1
2022
164
0.180
Why?
Chromosome Fragile Sites
2
2010
6
0.180
Why?
Fever
1
2020
125
0.180
Why?
Mitoxantrone
1
2020
68
0.180
Why?
Head Injuries, Penetrating
1
2021
54
0.180
Why?
Blood Coagulation Disorders
1
2021
63
0.180
Why?
Estrogens
1
2020
200
0.180
Why?
Robotic Surgical Procedures
2
2016
267
0.180
Why?
Cytochrome P-450 CYP2C9
1
2019
21
0.180
Why?
B7-H1 Antigen
2
2023
250
0.180
Why?
Dexamethasone
6
2023
326
0.180
Why?
Receptors, Vascular Endothelial Growth Factor
2
2023
70
0.180
Why?
Celecoxib
1
2019
31
0.170
Why?
Infant, Newborn
15
2017
2379
0.170
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2019
100
0.170
Why?
Drug Administration Schedule
7
2020
916
0.170
Why?
Urinary Bladder Neoplasms
1
2023
383
0.170
Why?
Child, Preschool
13
2016
3613
0.170
Why?
Mutation
8
2023
3968
0.170
Why?
Cohort Studies
10
2021
2768
0.170
Why?
Clinical Chemistry Tests
1
2019
11
0.170
Why?
Ulcer
1
2019
36
0.170
Why?
Ileal Diseases
1
2019
25
0.170
Why?
TOR Serine-Threonine Kinases
5
2022
182
0.170
Why?
Brain Injuries, Traumatic
1
2021
86
0.170
Why?
Geographic Mapping
1
2018
12
0.170
Why?
Confidence Intervals
2
1996
229
0.170
Why?
Electroconvulsive Therapy
1
2019
24
0.170
Why?
Pyrroles
3
2015
184
0.170
Why?
Brain Ischemia
1
2023
398
0.160
Why?
Pancreatic Neoplasms
3
2019
645
0.160
Why?
Decision Support Systems, Clinical
1
2019
103
0.160
Why?
Rituximab
1
2019
116
0.160
Why?
Hyperparathyroidism, Primary
1
2019
41
0.160
Why?
Animals
30
2023
26590
0.160
Why?
Thyroid Neoplasms
1
2023
408
0.160
Why?
Azacitidine
2
2020
137
0.160
Why?
Neuroblastoma
1
2022
375
0.160
Why?
Proto-Oncogene Proteins c-kit
2
2015
79
0.160
Why?
Parathyroidectomy
1
2019
78
0.160
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
375
0.160
Why?
Recurrence
6
2023
1139
0.160
Why?
Ileum
1
2019
159
0.160
Why?
Adoptive Transfer
2
2017
168
0.160
Why?
Hypertension
3
2017
1142
0.160
Why?
Proto-Oncogene Proteins c-myc
1
2019
120
0.160
Why?
Pain Management
1
2019
127
0.160
Why?
Induction Chemotherapy
4
2022
147
0.160
Why?
Analysis of Variance
4
2010
912
0.160
Why?
Trauma Centers
1
2018
116
0.160
Why?
Neoadjuvant Therapy
1
2020
318
0.160
Why?
Salvage Therapy
3
2022
233
0.160
Why?
Parathyroid Hormone
1
2019
218
0.160
Why?
Uterine Cervical Neoplasms
1
2020
275
0.160
Why?
Laparoscopy
2
2016
754
0.150
Why?
Nigeria
4
2020
152
0.150
Why?
Antigens, Neoplasm
3
2017
325
0.150
Why?
Food
1
2018
86
0.150
Why?
Necrosis
1
2018
204
0.150
Why?
Receptors, Antigen, T-Cell
1
2019
371
0.150
Why?
Mice, Inbred C57BL
8
2020
3095
0.150
Why?
Endoscopy
1
2020
332
0.150
Why?
Emergency Service, Hospital
4
2003
484
0.150
Why?
Ovarian Neoplasms
3
2012
744
0.150
Why?
Calcaneus
2
2007
34
0.150
Why?
Hematologic Neoplasms
2
2014
329
0.150
Why?
Diabetes Mellitus, Type 2
3
2012
1375
0.150
Why?
Receptor, ErbB-2
2
2016
223
0.150
Why?
Deoxycytidine
5
2015
237
0.150
Why?
Logistic Models
7
2016
1188
0.150
Why?
Multivariate Analysis
8
2016
1001
0.150
Why?
Nuclear Proteins
2
2016
696
0.150
Why?
Seasons
1
1998
223
0.140
Why?
Erythropoiesis
2
2013
52
0.140
Why?
Pregnancy Complications, Cardiovascular
1
2017
104
0.140
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2008
173
0.140
Why?
Gene Expression Regulation, Neoplastic
2
2016
1197
0.140
Why?
Cyclin-Dependent Kinase 2
1
2016
25
0.140
Why?
Erlotinib Hydrochloride
4
2011
90
0.140
Why?
Hypersensitivity
1
1998
154
0.140
Why?
Area Under Curve
5
2019
334
0.140
Why?
Peptide Termination Factors
1
2016
5
0.140
Why?
Receptor, ErbB-3
1
2016
18
0.140
Why?
Heart Diseases
1
2019
290
0.140
Why?
Critical Care
1
2019
370
0.140
Why?
Forms and Records Control
2
2009
16
0.140
Why?
Neoplasm, Residual
3
2022
162
0.140
Why?
Unrelated Donors
1
2016
50
0.140
Why?
Feasibility Studies
4
2022
751
0.140
Why?
Neovascularization, Pathologic
2
2015
353
0.140
Why?
Gastrointestinal Transit
4
2005
19
0.140
Why?
Radiotherapy Dosage
5
2023
468
0.140
Why?
Guanine
3
2014
208
0.140
Why?
Dasatinib
1
2015
37
0.140
Why?
Weight Loss
1
1997
229
0.140
Why?
Exanthema
2
2014
36
0.140
Why?
Risk Assessment
8
2019
2264
0.140
Why?
Urothelium
1
2016
70
0.140
Why?
Carcinoma, Adenoid Cystic
1
2015
28
0.130
Why?
Retroviridae
1
2016
79
0.130
Why?
Mutagenesis, Insertional
1
2016
111
0.130
Why?
Colon
1
2019
496
0.130
Why?
Pneumonia, Viral
1
2020
316
0.130
Why?
Immunization
4
2013
158
0.130
Why?
Patient Education as Topic
2
2000
351
0.130
Why?
Forced Expiratory Volume
3
2008
122
0.130
Why?
Histone-Lysine N-Methyltransferase
1
2016
154
0.130
Why?
Collagen Type I
1
2015
62
0.130
Why?
Cancer Vaccines
2
2013
156
0.130
Why?
Child
15
2016
6928
0.130
Why?
Urologic Neoplasms
1
2016
77
0.130
Why?
Wnt Signaling Pathway
1
2016
91
0.130
Why?
Family Health
1
2015
162
0.130
Why?
Gene Expression
4
2014
1284
0.130
Why?
Hedgehog Proteins
1
2015
93
0.130
Why?
Transplantation, Autologous
4
2022
331
0.130
Why?
Amino Acid Substitution
1
2016
339
0.130
Why?
Salivary Gland Neoplasms
1
2015
66
0.130
Why?
Rheumatic Heart Disease
1
1995
29
0.130
Why?
Cell Line, Tumor
7
2019
2426
0.130
Why?
Toxoplasmosis
1
2015
64
0.130
Why?
Fathers
1
2015
70
0.130
Why?
Hydroxamic Acids
1
2014
49
0.130
Why?
Hydrocephalus
1
2015
101
0.120
Why?
Immunologic Memory
2
2013
152
0.120
Why?
Cluster Analysis
1
2015
369
0.120
Why?
Organoplatinum Compounds
1
2014
94
0.120
Why?
Risk Factors
11
2014
5420
0.120
Why?
Spleen
2
2013
430
0.120
Why?
Histone Deacetylase Inhibitors
1
2014
85
0.120
Why?
Myocarditis
1
1995
51
0.120
Why?
Urinary Catheters
1
2014
6
0.120
Why?
Stroke
1
2023
965
0.120
Why?
Signal Transduction
6
2015
3243
0.120
Why?
Gene Amplification
1
2014
131
0.120
Why?
Angiopoietin-2
1
2014
15
0.120
Why?
Indazoles
4
2016
68
0.120
Why?
Lymph Node Excision
1
2015
217
0.120
Why?
CD4-Positive T-Lymphocytes
1
2017
425
0.120
Why?
Genes, APC
1
2013
26
0.120
Why?
Testosterone
3
2018
271
0.120
Why?
Urinary Catheterization
1
2014
35
0.120
Why?
Infant
6
2023
3047
0.120
Why?
Antigens, CD34
2
2008
158
0.120
Why?
Transcription Factors
4
2016
1565
0.120
Why?
Mass Spectrometry
1
2014
189
0.120
Why?
Adenomatous Polyposis Coli Protein
1
2013
40
0.120
Why?
Granulocyte Colony-Stimulating Factor
2
2008
165
0.120
Why?
Oxidative Stress
1
2016
448
0.120
Why?
Genes, p53
1
2013
109
0.120
Why?
Receptors, Growth Factor
2
2011
52
0.120
Why?
Chromosomes, Human, Pair 5
1
2013
109
0.120
Why?
Bacterial Vaccines
1
2013
41
0.120
Why?
Kerosene
3
2017
17
0.110
Why?
Myeloid Cells
1
2013
98
0.110
Why?
Blood Proteins
1
2014
144
0.110
Why?
Receptor, EphB4
1
2013
24
0.110
Why?
Food-Drug Interactions
1
2013
18
0.110
Why?
Histones
3
2016
311
0.110
Why?
Drainage
1
2014
157
0.110
Why?
Carboplatin
3
2022
286
0.110
Why?
Tomography, X-Ray Computed
2
2009
2601
0.110
Why?
T-Lymphocytes
5
2012
1195
0.110
Why?
Public Opinion
1
1993
43
0.110
Why?
Age Factors
7
2019
1852
0.110
Why?
Peritoneal Neoplasms
2
2012
177
0.110
Why?
Melanoma, Experimental
1
2013
103
0.110
Why?
Clinical Laboratory Techniques
2
2011
73
0.110
Why?
Erythroblastosis, Fetal
2
2002
7
0.110
Why?
Coombs Test
2
2002
8
0.110
Why?
src-Family Kinases
1
2012
75
0.110
Why?
Resource Allocation
1
1993
65
0.110
Why?
Random Allocation
4
2003
332
0.110
Why?
Remission Induction
4
2020
722
0.110
Why?
Obesity
2
1997
964
0.110
Why?
Crohn Disease
1
2019
730
0.110
Why?
Mice, Knockout
4
2020
1924
0.110
Why?
Health Care Rationing
1
1993
83
0.110
Why?
Device Removal
1
2014
161
0.110
Why?
Pain
3
2022
391
0.110
Why?
Proteomics
1
2014
211
0.110
Why?
Bevacizumab
5
2012
281
0.100
Why?
Programmed Cell Death 1 Receptor
1
2013
159
0.100
Why?
Proteins
2
2016
777
0.100
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2011
20
0.100
Why?
Translocation, Genetic
2
2019
265
0.100
Why?
Carbon Monoxide
3
2017
90
0.100
Why?
Peptides
1
2015
639
0.100
Why?
Trastuzumab
2
2023
68
0.100
Why?
Food Contamination
1
2011
31
0.100
Why?
T-Lymphocyte Subsets
1
2013
272
0.100
Why?
MAP Kinase Kinase 4
2
2002
67
0.100
Why?
Carcinoma, Large Cell
1
2011
39
0.100
Why?
Ear, External
1
1991
26
0.100
Why?
Databases, Factual
2
2016
816
0.100
Why?
Attitude to Health
1
1993
220
0.100
Why?
Thalidomide
1
2011
54
0.100
Why?
Genes, Tumor Suppressor
2
2002
157
0.100
Why?
Delivery, Obstetric
3
1998
112
0.100
Why?
Tumor Suppressor Protein p53
1
2013
381
0.100
Why?
Tissue Banks
1
2011
16
0.100
Why?
Gene Expression Profiling
4
2020
1384
0.100
Why?
Magnetic Resonance Imaging
2
2016
3362
0.100
Why?
Insulin
7
1995
1160
0.100
Why?
Diagnostic Tests, Routine
1
1991
62
0.100
Why?
Lymph Nodes
4
2022
533
0.100
Why?
Mouth Neoplasms
2
2007
194
0.090
Why?
Eating
1
2011
166
0.090
Why?
T-Lymphocytes, Cytotoxic
1
2012
315
0.090
Why?
Thoracic Neoplasms
1
2011
64
0.090
Why?
Macrophages
1
2013
557
0.090
Why?
Severity of Illness Index
4
2020
1802
0.090
Why?
DNA-Binding Proteins
4
2016
1208
0.090
Why?
Receptor Protein-Tyrosine Kinases
1
2011
153
0.090
Why?
United States
9
2018
6681
0.090
Why?
Breath Tests
4
2002
55
0.090
Why?
Drug Interactions
4
2019
248
0.090
Why?
Acid Anhydride Hydrolases
1
2010
13
0.090
Why?
Coronary Disease
1
1991
261
0.090
Why?
Peripheral Nervous System Neoplasms
1
2009
19
0.090
Why?
Proto-Oncogene Proteins c-cbl
1
2010
36
0.090
Why?
Schwann Cells
1
2009
34
0.090
Why?
Risk
4
2007
674
0.090
Why?
DNA Replication
2
2010
164
0.090
Why?
Morphine
2
2002
130
0.090
Why?
Everolimus
2
2022
40
0.090
Why?
Lymphatic Metastasis
5
2015
486
0.090
Why?
Mice, Transgenic
5
2013
1540
0.090
Why?
Leukemia, Myeloid
3
2007
249
0.090
Why?
Small Cell Lung Carcinoma
1
2011
98
0.090
Why?
Practice Management, Medical
1
2009
24
0.090
Why?
Genome-Wide Association Study
2
2014
1621
0.090
Why?
Odds Ratio
3
2015
680
0.090
Why?
Risk Management
1
2009
43
0.090
Why?
Mastectomy, Extended Radical
1
1989
1
0.090
Why?
Antibodies, Protozoan
3
2015
34
0.090
Why?
Radiography, Thoracic
1
1991
320
0.090
Why?
Blood Pressure Monitoring, Ambulatory
1
2009
83
0.090
Why?
Glucocorticoids
2
2018
352
0.080
Why?
Patient Selection
1
1993
686
0.080
Why?
Outpatients
1
2009
94
0.080
Why?
Quality of Health Care
3
2001
381
0.080
Why?
Hypoglycemic Agents
1
2012
378
0.080
Why?
Prednisone
3
2019
258
0.080
Why?
Pulmonary Diffusing Capacity
1
2008
24
0.080
Why?
Epidemiologic Methods
1
2008
59
0.080
Why?
Antineoplastic Agents, Hormonal
3
2021
150
0.080
Why?
Neoplasms, Second Primary
2
2003
252
0.080
Why?
Tumor Necrosis Factors
1
2008
14
0.080
Why?
Respiration, Artificial
1
1991
334
0.080
Why?
Bystander Effect
1
2008
12
0.080
Why?
Drug Synergism
3
2018
303
0.080
Why?
Mutation, Missense
1
2010
276
0.080
Why?
Quinoxalines
1
2008
50
0.080
Why?
Medical Errors
1
2009
115
0.080
Why?
Biopsy
3
2023
1163
0.080
Why?
Blood Component Removal
1
2008
24
0.080
Why?
Insurance, Health
1
2009
160
0.080
Why?
Cell Transformation, Neoplastic
2
2013
427
0.080
Why?
Protein Kinases
1
2009
209
0.080
Why?
Wood
2
2017
19
0.080
Why?
Cytogenetic Analysis
3
2019
71
0.080
Why?
Fusion Proteins, bcr-abl
1
2008
107
0.080
Why?
Lymphocytes
5
1990
464
0.080
Why?
Neutropenia
2
2008
215
0.080
Why?
Blood Viscosity
1
2007
16
0.080
Why?
Absorptiometry, Photon
1
2007
99
0.080
Why?
Apoptosis
4
2013
1683
0.080
Why?
Tubulin Modulators
1
2007
24
0.070
Why?
Reishi
1
2007
7
0.070
Why?
O(6)-Methylguanine-DNA Methyltransferase
5
2002
118
0.070
Why?
Acute Disease
4
2022
826
0.070
Why?
C-Peptide
5
1988
174
0.070
Why?
Peripheral Vascular Diseases
1
2007
62
0.070
Why?
DNA Repair
4
2004
356
0.070
Why?
Antigens
1
2008
228
0.070
Why?
Radiotherapy, Adjuvant
3
2016
292
0.070
Why?
Bias
2
1998
127
0.070
Why?
Cell Survival
4
2016
969
0.070
Why?
Toxoplasmosis, Ocular
1
2006
17
0.070
Why?
Drugs, Chinese Herbal
1
2007
67
0.070
Why?
Phosphorylcholine
1
2006
28
0.070
Why?
Deoxyepinephrine
1
1986
1
0.070
Why?
Mexiletine
1
1986
3
0.070
Why?
Osteoporosis, Postmenopausal
1
2006
34
0.070
Why?
Bone Density
3
2007
209
0.070
Why?
Phosphorylation
3
2018
1106
0.070
Why?
Bryostatins
1
2006
15
0.070
Why?
Propylamines
1
1986
9
0.070
Why?
Analgesics, Opioid
2
2002
413
0.070
Why?
Antiprotozoal Agents
1
2006
33
0.070
Why?
Interferon-gamma
1
2008
444
0.070
Why?
Postoperative Care
2
2014
221
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2010
378
0.070
Why?
Precancerous Conditions
1
2007
196
0.070
Why?
Vision Disorders
1
2006
75
0.070
Why?
Glucosephosphate Dehydrogenase Deficiency
1
2005
8
0.070
Why?
Immunohistochemistry
5
2014
1753
0.070
Why?
Birth Weight
4
2017
145
0.070
Why?
Muscles
2
2023
194
0.070
Why?
Bilirubin
2
2004
125
0.070
Why?
Jaundice, Neonatal
2
2002
32
0.070
Why?
Norepinephrine
1
1986
167
0.070
Why?
Benzamides
2
2022
229
0.070
Why?
Myocardium
6
1986
529
0.070
Why?
Linear Models
3
2015
422
0.070
Why?
Proto-Oncogene Proteins
2
2011
645
0.070
Why?
Cesarean Section
4
2001
137
0.070
Why?
Hemolysis
1
2005
61
0.070
Why?
Lupus Erythematosus, Systemic
1
2007
206
0.070
Why?
Evaluation Studies as Topic
2
1998
274
0.070
Why?
Oligonucleotide Array Sequence Analysis
2
2006
689
0.060
Why?
Immunotherapy
2
2022
629
0.060
Why?
Bone Marrow
3
2013
435
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2015
376
0.060
Why?
Epithelial Cells
3
2022
669
0.060
Why?
Methyltransferases
4
1990
182
0.060
Why?
Fractures, Bone
1
2006
131
0.060
Why?
Thyrotoxicosis
1
2004
18
0.060
Why?
Placebos
3
2012
218
0.060
Why?
Breech Presentation
2
1994
12
0.060
Why?
Cytarabine
2
2020
218
0.060
Why?
Pain, Postoperative
2
2019
240
0.060
Why?
Genome, Human
1
2009
756
0.060
Why?
Plant Preparations
1
2004
19
0.060
Why?
Arrhythmias, Cardiac
1
1986
187
0.060
Why?
Hematopoietic Stem Cell Mobilization
2
2008
50
0.060
Why?
Carrier Proteins
2
1985
673
0.060
Why?
Quinolones
1
2004
60
0.060
Why?
Glutathione
1
2004
104
0.060
Why?
Barrett Esophagus
1
2005
93
0.060
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2007
467
0.060
Why?
Cognition Disorders
1
2006
236
0.060
Why?
Dopamine
1
1986
275
0.060
Why?
Topoisomerase I Inhibitors
1
2004
33
0.060
Why?
Lymphoma, T-Cell
1
2004
48
0.060
Why?
Phosphoprotein Phosphatases
1
2004
57
0.060
Why?
Suramin
1
2004
27
0.060
Why?
RNA, Small Interfering
3
2013
547
0.060
Why?
Models, Theoretical
1
2007
482
0.060
Why?
Receptors, Estrogen
2
1987
384
0.060
Why?
Nimodipine
1
2003
11
0.060
Why?
Abortion, Spontaneous
1
2004
66
0.060
Why?
Body Weights and Measures
1
2003
27
0.060
Why?
Warfarin
1
2004
103
0.060
Why?
Genomics
2
2023
720
0.060
Why?
Thyroid Hormone Resistance Syndrome
1
2004
116
0.060
Why?
Urban Population
3
2003
214
0.060
Why?
Thyrotropin
1
2004
280
0.060
Why?
Circadian Rhythm
2
2009
303
0.060
Why?
Receptors, Cell Surface
1
1985
286
0.060
Why?
ras Proteins
1
2004
128
0.060
Why?
Health Status
2
1999
360
0.060
Why?
Tissue Array Analysis
2
2016
124
0.060
Why?
Injections, Intravenous
6
2005
244
0.060
Why?
Phytotherapy
1
2004
133
0.060
Why?
Hydroxyurea
2
2014
239
0.060
Why?
Mass Screening
1
2007
619
0.060
Why?
Angiography
1
2003
208
0.060
Why?
Colonic Pouches
1
2003
67
0.050
Why?
Iodine Radioisotopes
1
2023
134
0.050
Why?
Imides
1
2022
26
0.050
Why?
Fibrin Fibrinogen Degradation Products
1
2022
28
0.050
Why?
Rh Isoimmunization
1
2002
7
0.050
Why?
Asparaginase
1
2022
35
0.050
Why?
Panax
1
2004
170
0.050
Why?
Proctocolectomy, Restorative
1
2003
87
0.050
Why?
Proteasome Inhibitors
1
2022
51
0.050
Why?
Androgen Receptor Antagonists
1
2022
18
0.050
Why?
Mice, Inbred C3H
2
2013
370
0.050
Why?
Leukocytes, Mononuclear
2
2018
196
0.050
Why?
Omeprazole
1
2022
11
0.050
Why?
Succinylcholine
1
2022
14
0.050
Why?
Hydralazine
1
2022
20
0.050
Why?
Mifepristone
1
2022
33
0.050
Why?
Pelvis
1
2022
95
0.050
Why?
Intracranial Hemorrhages
1
2023
120
0.050
Why?
Phenylthiohydantoin
1
2022
41
0.050
Why?
Peripheral Nervous System
1
2002
21
0.050
Why?
Adrenal Cortex Hormones
2
1995
263
0.050
Why?
Thyroid Hormones
1
2004
321
0.050
Why?
Quaternary Ammonium Compounds
4
2005
79
0.050
Why?
Patient Reported Outcome Measures
1
2023
166
0.050
Why?
Flow Cytometry
3
2012
679
0.050
Why?
Thrombectomy
1
2023
158
0.050
Why?
Radiotherapy, High-Energy
2
2010
49
0.050
Why?
Oxycodone
1
2022
35
0.050
Why?
Nitriles
1
2022
149
0.050
Why?
Cytochrome P-450 CYP2D6
1
2022
52
0.050
Why?
Patient Satisfaction
2
2003
455
0.050
Why?
Activities of Daily Living
2
1999
204
0.050
Why?
Gene Dosage
2
2013
207
0.050
Why?
Office Management
1
1981
1
0.050
Why?
Filing
1
1981
3
0.050
Why?
Disease Models, Animal
2
2019
2231
0.050
Why?
Vaginal Birth after Cesarean
1
2001
7
0.050
Why?
Geriatric Assessment
1
2003
166
0.050
Why?
Pregnancy Complications
1
2004
336
0.050
Why?
Smoking
2
2016
609
0.050
Why?
Phosphatidylinositol 3-Kinases
1
2022
262
0.050
Why?
Serotonin Uptake Inhibitors
1
2001
7
0.050
Why?
Desipramine
1
2001
9
0.050
Why?
Computers
1
1981
112
0.050
Why?
Drug Therapy, Combination
1
2003
895
0.050
Why?
Receptors, Interleukin-6
1
2020
17
0.050
Why?
Health Services for the Aged
1
2001
27
0.050
Why?
Triazolam
1
2000
5
0.050
Why?
Anticoagulants
1
2004
408
0.050
Why?
Receptors, Glucocorticoid
1
2022
120
0.050
Why?
Paroxetine
1
2001
26
0.050
Why?
Sleep Disorders, Circadian Rhythm
1
2000
13
0.050
Why?
Anti-Anxiety Agents
1
2000
23
0.050
Why?
Hepatocyte Growth Factor
2
2011
84
0.050
Why?
JNK Mitogen-Activated Protein Kinases
1
2001
113
0.050
Why?
Human papillomavirus 16
1
2020
38
0.050
Why?
Vincristine
2
2019
111
0.050
Why?
Histocompatibility Antigens Class I
1
2001
203
0.050
Why?
Hemorrhage
1
2022
268
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2010
879
0.050
Why?
HLA Antigens
1
2001
232
0.050
Why?
Administration, Intravenous
1
2020
50
0.050
Why?
Drug Utilization Review
1
1999
14
0.050
Why?
Ethylnitrosourea
2
2013
30
0.050
Why?
Multicenter Studies as Topic
1
2020
159
0.050
Why?
Mucositis
2
2010
17
0.050
Why?
Emergency Medical Services
1
2003
209
0.050
Why?
Sickness Impact Profile
1
1999
27
0.050
Why?
Mortality
1
2001
149
0.040
Why?
PTEN Phosphohydrolase
1
2020
128
0.040
Why?
Dogs
3
1998
686
0.040
Why?
Needs Assessment
1
2001
154
0.040
Why?
Methadone
1
2000
36
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2020
154
0.040
Why?
Prevalence
2
2015
1239
0.040
Why?
Injections, Intralesional
1
1999
22
0.040
Why?
Medication Errors
1
1999
39
0.040
Why?
Doxorubicin
2
2019
295
0.040
Why?
Hydrazines
1
2019
30
0.040
Why?
Dose-Response Relationship, Radiation
2
2018
188
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2023
456
0.040
Why?
Gestational Age
2
2017
311
0.040
Why?
Constipation
1
2000
63
0.040
Why?
Tumor Cells, Cultured
4
2004
1041
0.040
Why?
Carcinoma in Situ
1
1999
53
0.040
Why?
Catheterization, Peripheral
1
1999
58
0.040
Why?
Retreatment
1
2019
107
0.040
Why?
Pilot Projects
2
2018
840
0.040
Why?
Emergencies
1
1999
113
0.040
Why?
Leukapheresis
1
1999
19
0.040
Why?
Albumins
1
2019
133
0.040
Why?
Intraoperative Period
1
2019
90
0.040
Why?
Inflammatory Bowel Diseases
2
1998
549
0.040
Why?
Community Health Services
1
2000
80
0.040
Why?
Postpartum Period
1
2000
135
0.040
Why?
Radiography
2
2014
813
0.040
Why?
Birth Rate
1
1998
12
0.040
Why?
Biliary Tract Neoplasms
1
2019
33
0.040
Why?
Abiraterone Acetate
1
2018
11
0.040
Why?
Diarrhea
2
2011
182
0.040
Why?
Carcinogenesis
1
2020
195
0.040
Why?
Hysterectomy
1
2000
146
0.040
Why?
Maintenance Chemotherapy
1
2019
76
0.040
Why?
Triazoles
1
2019
96
0.040
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1999
112
0.040
Why?
Reproducibility of Results
3
2007
2706
0.040
Why?
Fatigue
2
2011
174
0.040
Why?
Etoposide
1
2019
196
0.040
Why?
Point-of-Care Systems
1
2019
141
0.040
Why?
Singapore
1
2018
16
0.040
Why?
Skin Tests
1
1998
44
0.040
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
44
0.040
Why?
Microsatellite Repeats
1
1998
145
0.040
Why?
Mites
1
1998
16
0.040
Why?
Antigens, Differentiation
1
1998
141
0.040
Why?
Cross Infection
1
1999
141
0.040
Why?
Epigenesis, Genetic
2
2014
481
0.040
Why?
Oligopeptides
1
2019
179
0.040
Why?
Dehydroepiandrosterone
1
2018
51
0.040
Why?
Adaptation, Physiological
1
2000
306
0.040
Why?
Cyclophosphamide
1
2019
299
0.040
Why?
Affect
1
2001
386
0.040
Why?
Immunoglobulin M
2
2015
154
0.040
Why?
Anti-Inflammatory Agents
1
2020
339
0.040
Why?
Chromosomes, Human, Pair 11
2
2010
106
0.040
Why?
Monocytes
1
1999
216
0.040
Why?
Response Evaluation Criteria in Solid Tumors
1
2018
56
0.040
Why?
Incidence
3
2015
1578
0.040
Why?
Piperazines
2
2011
272
0.040
Why?
Carcinoma, Ductal, Breast
1
1999
157
0.040
Why?
Body Constitution
1
1997
26
0.040
Why?
Immunoconjugates
1
1998
106
0.040
Why?
Cats
1
1998
304
0.040
Why?
Contrast Media
2
2016
1078
0.040
Why?
Positron-Emission Tomography
1
2020
329
0.040
Why?
Islets of Langerhans
3
1994
544
0.040
Why?
Analgesics, Non-Narcotic
1
1998
46
0.040
Why?
Acetaminophen
1
1998
54
0.040
Why?
Alcoholism
1
1999
172
0.040
Why?
Nephrotic Syndrome
1
1997
33
0.040
Why?
Predictive Value of Tests
3
2014
1673
0.040
Why?
Anastomosis, Surgical
1
2019
267
0.040
Why?
Fasting
1
2018
161
0.040
Why?
Infant Mortality
2
1994
59
0.040
Why?
Digestive System Surgical Procedures
1
2019
120
0.040
Why?
Psychomotor Performance
1
2001
492
0.040
Why?
Environmental Monitoring
1
2017
71
0.040
Why?
Leukocytes
1
1998
202
0.040
Why?
Ultrasonography, Prenatal
1
1998
152
0.040
Why?
Penicillamine
1
1997
12
0.040
Why?
Urinary Bladder Neck Obstruction
1
1997
21
0.040
Why?
Comorbidity
1
2021
944
0.040
Why?
Patient Readmission
1
2001
329
0.040
Why?
Cell Line
5
2009
2469
0.040
Why?
Religion
1
1997
87
0.040
Why?
Gene Expression Regulation
1
2006
1921
0.040
Why?
Liver Cirrhosis, Biliary
1
1997
29
0.040
Why?
Particulate Matter
1
2017
79
0.040
Why?
Dust
1
1997
26
0.040
Why?
Patient Safety
1
2019
212
0.040
Why?
Household Products
1
2016
9
0.040
Why?
Biofuels
1
2016
10
0.040
Why?
Cystoscopy
1
1997
35
0.040
Why?
Social Support
1
1998
193
0.040
Why?
Lymphocyte Count
1
2017
94
0.040
Why?
Colonoscopy
1
2019
267
0.040
Why?
Lidocaine
1
1997
63
0.040
Why?
Body Mass Index
2
1997
770
0.040
Why?
Hematopoietic Stem Cells
1
1999
292
0.040
Why?
Pregnant Women
1
2016
35
0.040
Why?
Antirheumatic Agents
1
1997
54
0.040
Why?
Schools
1
1997
71
0.040
Why?
Transcriptome
1
2021
580
0.040
Why?
Colitis, Ulcerative
1
2003
711
0.040
Why?
Air Pollutants
1
2017
78
0.040
Why?
Unsupervised Machine Learning
1
2016
7
0.040
Why?
Cell Differentiation
3
2009
1458
0.040
Why?
Heart Failure
1
1986
1204
0.040
Why?
DNA Methylation
2
2016
628
0.040
Why?
Immunoglobulin G
2
2015
456
0.040
Why?
Waiting Lists
1
1997
175
0.040
Why?
Anesthetics, Local
1
1997
76
0.030
Why?
Histocompatibility
1
2016
71
0.030
Why?
Histocompatibility Antigens Class II
1
2017
158
0.030
Why?
Loss of Heterozygosity
2
2010
85
0.030
Why?
Body Weight
1
1997
459
0.030
Why?
Chromatin Immunoprecipitation
1
2016
133
0.030
Why?
Cell Cycle
2
2016
502
0.030
Why?
Premature Birth
1
2017
113
0.030
Why?
Creatinine
1
1997
339
0.030
Why?
Hospital Costs
1
1997
107
0.030
Why?
Margins of Excision
1
2016
39
0.030
Why?
Agglutination Tests
1
2015
11
0.030
Why?
Serogroup
1
2015
9
0.030
Why?
Karnofsky Performance Status
1
2015
40
0.030
Why?
Prostatic Hyperplasia
1
1997
88
0.030
Why?
Blotting, Western
2
2010
782
0.030
Why?
Heart
4
1986
539
0.030
Why?
Infusions, Intravenous
2
2008
430
0.030
Why?
Snake Venoms
1
2015
10
0.030
Why?
Mice, Mutant Strains
1
2016
229
0.030
Why?
Air Pollution
1
2016
68
0.030
Why?
Cell Nucleus
1
2018
580
0.030
Why?
Sex Factors
1
2019
1055
0.030
Why?
Interleukin-6
1
2016
256
0.030
Why?
Visual Acuity
2
2006
194
0.030
Why?
Pain Measurement
1
1997
321
0.030
Why?
Diabetes Mellitus
2
2000
806
0.030
Why?
Likelihood Functions
1
1996
251
0.030
Why?
Exercise
2
2014
315
0.030
Why?
Mastectomy, Segmental
2
2010
93
0.030
Why?
Reference Values
5
1998
674
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2014
24
0.030
Why?
Anemia, Sickle Cell
1
1997
131
0.030
Why?
Recombinant Proteins
2
2008
1015
0.030
Why?
Genetic Vectors
1
2016
439
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2014
74
0.030
Why?
Infant, Low Birth Weight
1
1994
58
0.030
Why?
Cells, Cultured
2
2013
2819
0.030
Why?
Blood Glucose
6
2000
873
0.030
Why?
Attitude of Health Personnel
1
2019
636
0.030
Why?
Skin Window Technique
1
2013
3
0.030
Why?
Anemia, Macrocytic
1
2013
5
0.030
Why?
Hospitals
1
1997
294
0.030
Why?
Receptors, Chemokine
1
2013
31
0.030
Why?
CD11b Antigen
1
2013
36
0.030
Why?
Taxoids
1
2014
129
0.030
Why?
Practice Patterns, Physicians'
1
2019
584
0.030
Why?
Carcinoma, Intraductal, Noninfiltrating
2
1986
113
0.030
Why?
Genes, Lethal
1
2013
53
0.030
Why?
Erythroblasts
1
2013
25
0.030
Why?
Pemetrexed
1
2014
76
0.030
Why?
Cellular Microenvironment
1
2013
27
0.030
Why?
Glutamates
1
2014
89
0.030
Why?
Erythrocyte Count
1
2013
23
0.030
Why?
Pyrimethamine
2
2006
21
0.030
Why?
Aspirin
1
1995
156
0.030
Why?
Quality Control
2
1986
117
0.030
Why?
Sulfadiazine
2
2006
24
0.030
Why?
S Phase
2
2010
62
0.030
Why?
Genes, ras
1
2013
96
0.030
Why?
Muscular Dystrophies
2
1984
54
0.030
Why?
Ovalbumin
1
2013
109
0.030
Why?
Erythropoietin
1
2013
91
0.030
Why?
Autopsy
1
2013
116
0.030
Why?
Polycystic Ovary Syndrome
1
1995
203
0.030
Why?
fms-Like Tyrosine Kinase 3
1
2013
127
0.030
Why?
Cystic Fibrosis
1
1994
112
0.030
Why?
Epitopes
1
2013
255
0.030
Why?
Insulin Resistance
1
1995
377
0.030
Why?
Treatment Refusal
1
1993
60
0.030
Why?
Heterozygote
1
2013
365
0.030
Why?
Moral Obligations
1
1993
52
0.030
Why?
Life Support Care
1
1993
49
0.030
Why?
Gene Deletion
1
2013
329
0.030
Why?
Imidazoles
1
2013
162
0.030
Why?
Serotyping
1
2012
28
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2013
123
0.030
Why?
Intraocular Pressure
1
1992
54
0.030
Why?
Cell Membrane
5
1986
666
0.030
Why?
Infant, Premature
1
1994
290
0.030
Why?
Withholding Treatment
1
1993
112
0.030
Why?
Autoantibodies
1
1993
267
0.030
Why?
Antigen Presentation
1
2013
209
0.030
Why?
United States Department of Defense
1
2011
5
0.030
Why?
Oocysts
1
2011
7
0.030
Why?
Up-Regulation
1
2014
715
0.030
Why?
Early Termination of Clinical Trials
1
2011
20
0.030
Why?
Hospitalization
1
1997
851
0.030
Why?
Glucose
3
1995
638
0.030
Why?
Xenograft Model Antitumor Assays
1
2013
458
0.030
Why?
Orchiectomy
1
2011
68
0.030
Why?
Kidney
1
1997
1242
0.030
Why?
Death, Sudden
1
1991
40
0.030
Why?
Peptide Fragments
1
2013
460
0.020
Why?
North America
1
2011
180
0.020
Why?
Virulence
1
2012
271
0.020
Why?
Pleural Effusion
1
1991
45
0.020
Why?
DNA, Neoplasm
1
2012
265
0.020
Why?
STAT3 Transcription Factor
1
2011
78
0.020
Why?
MAP Kinase Signaling System
2
2002
192
0.020
Why?
Regression Analysis
2
2009
596
0.020
Why?
Tissue Donors
1
1994
464
0.020
Why?
Phospholipids
2
2006
111
0.020
Why?
Herbicides
1
1990
35
0.020
Why?
Pneumothorax
1
1991
52
0.020
Why?
Uterine Hemorrhage
2
2001
19
0.020
Why?
Uterine Diseases
2
2001
19
0.020
Why?
Universities
1
2011
135
0.020
Why?
In Situ Hybridization, Fluorescence
1
2011
348
0.020
Why?
Lymphocyte Activation
1
2013
728
0.020
Why?
Enzyme Activation
2
2002
692
0.020
Why?
Cross-Over Studies
1
2011
399
0.020
Why?
Lymphoma, Mantle-Cell
1
2010
35
0.020
Why?
Models, Biological
3
2013
1749
0.020
Why?
Aphidicolin
1
2010
4
0.020
Why?
Replication Origin
1
2010
5
0.020
Why?
Patient Compliance
1
2011
228
0.020
Why?
Hospitals, University
2
2001
194
0.020
Why?
Lymphoma, Follicular
1
2010
70
0.020
Why?
Paraffin Embedding
1
2010
78
0.020
Why?
Veterans
1
1990
72
0.020
Why?
Homeodomain Proteins
1
2013
536
0.020
Why?
Kidney Diseases
1
2013
418
0.020
Why?
Intubation, Intratracheal
1
1991
144
0.020
Why?
Polymerase Chain Reaction
1
2012
928
0.020
Why?
Quantitative Trait Loci
1
2013
577
0.020
Why?
Cell Movement
1
2013
758
0.020
Why?
Blood Transfusion
2
2001
157
0.020
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2010
136
0.020
Why?
Sister Chromatid Exchange
1
1989
12
0.020
Why?
Acetylation
1
2009
121
0.020
Why?
Mutagenesis, Site-Directed
1
2010
279
0.020
Why?
Castration
1
2009
41
0.020
Why?
RNA, Messenger
2
2006
1981
0.020
Why?
Tamoxifen
1
2010
168
0.020
Why?
Administration, Cutaneous
1
2009
58
0.020
Why?
Genomic Instability
1
2009
79
0.020
Why?
Muscle Strength
1
2009
31
0.020
Why?
Brachytherapy
1
2010
119
0.020
Why?
Transforming Growth Factor alpha
1
2009
50
0.020
Why?
DNA Primers
1
2010
543
0.020
Why?
Demography
1
2009
177
0.020
Why?
Pneumonia
1
2010
179
0.020
Why?
Morbidity
2
1999
148
0.020
Why?
Thiosemicarbazones
1
2008
6
0.020
Why?
Methemoglobinemia
1
2008
10
0.020
Why?
Neoplasms, Squamous Cell
1
2008
19
0.020
Why?
Receptors, Interferon
1
2008
31
0.020
Why?
Filgrastim
1
2008
56
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
43
0.020
Why?
Radiotherapy
1
2010
328
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2008
88
0.020
Why?
Tolonium Chloride
1
2007
5
0.020
Why?
Imatinib Mesylate
1
2008
126
0.020
Why?
Mercaptoethylamines
1
1988
52
0.020
Why?
Cytochrome P-450 Enzyme System
1
2008
79
0.020
Why?
Intensive Care Units
1
1991
374
0.020
Why?
Spectrophotometry
1
2007
106
0.020
Why?
Cytological Techniques
1
2007
30
0.020
Why?
Phosphoproteins
1
2009
255
0.020
Why?
Coloring Agents
1
2007
64
0.020
Why?
Fluorescence
1
2007
102
0.020
Why?
Radiation-Protective Agents
1
1988
96
0.020
Why?
Rheology
1
2007
39
0.020
Why?
ATP-Binding Cassette Transporters
1
2008
141
0.020
Why?
Gadolinium DTPA
1
2008
261
0.020
Why?
Microscopy, Electron
5
1986
503
0.020
Why?
Cell Proliferation
1
2013
1579
0.020
Why?
Length of Stay
2
2003
704
0.020
Why?
CD56 Antigen
1
2007
18
0.020
Why?
Stromal Cells
1
2008
143
0.020
Why?
Thirst
1
2007
19
0.020
Why?
Phenotype
1
2013
2380
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2009
302
0.020
Why?
Mammography
1
2010
463
0.020
Why?
Wechsler Scales
1
2006
21
0.020
Why?
Vision, Monocular
1
2006
15
0.020
Why?
Chromatin
1
2009
381
0.020
Why?
Intelligence Tests
1
2006
38
0.020
Why?
Femur Neck
1
2006
44
0.020
Why?
Language Tests
1
2006
37
0.020
Why?
Macula Lutea
1
2006
19
0.020
Why?
Vision, Binocular
1
2006
20
0.020
Why?
Fractals
1
2006
42
0.020
Why?
Chemistry, Clinical
1
1986
2
0.020
Why?
Metabolic Clearance Rate
4
1988
121
0.020
Why?
Physical Exertion
1
1986
39
0.020
Why?
Lewis X Antigen
1
2006
9
0.020
Why?
Myeloid Progenitor Cells
1
2006
15
0.020
Why?
Expressed Sequence Tags
1
2006
35
0.020
Why?
Polymorphism, Single Nucleotide
1
2014
2357
0.020
Why?
Rest
1
1986
48
0.020
Why?
Cricetinae
2
2002
560
0.020
Why?
Hip Joint
1
2006
55
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2006
125
0.020
Why?
Hyperbilirubinemia
1
2005
20
0.020
Why?
Base Sequence
1
2010
2330
0.020
Why?
Saxitoxin
1
1985
8
0.020
Why?
Chromosomes, Human, Pair 9
1
2006
86
0.020
Why?
Cardiac Output
1
1986
156
0.020
Why?
Gene Library
1
2006
130
0.020
Why?
Pulmonary Wedge Pressure
1
1986
108
0.020
Why?
International Cooperation
1
1986
127
0.020
Why?
Cornified Envelope Proline-Rich Proteins
1
2005
6
0.020
Why?
GATA6 Transcription Factor
1
2005
13
0.020
Why?
Lumbar Vertebrae
1
2006
148
0.020
Why?
Treatment Failure
1
2006
286
0.020
Why?
Half-Life
1
2005
96
0.020
Why?
Folate Receptors, GPI-Anchored
1
1985
2
0.020
Why?
DNA, Complementary
1
2006
393
0.020
Why?
Pattern Recognition, Visual
1
2006
151
0.020
Why?
Azores
1
2004
3
0.020
Why?
Freeze Fracturing
4
1985
12
0.020
Why?
Genes, erbA
1
2004
10
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2006
322
0.020
Why?
Zinc Fingers
1
2004
56
0.020
Why?
Biological Availability
1
2004
92
0.020
Why?
Proto-Oncogene Proteins c-bcl-6
1
2004
43
0.020
Why?
Fetal Death
2
1994
56
0.020
Why?
Platinum
1
2004
63
0.020
Why?
Oncogenes
1
2004
88
0.020
Why?
International Normalized Ratio
1
2004
38
0.020
Why?
Multigene Family
1
2005
202
0.020
Why?
Surveys and Questionnaires
2
2003
2504
0.020
Why?
Dual Specificity Phosphatase 1
1
2004
17
0.020
Why?
Sodium
1
1985
341
0.020
Why?
Protein Phosphatase 1
1
2004
34
0.010
Why?
Protein Tyrosine Phosphatases
1
2004
46
0.010
Why?
DNA
1
2010
1294
0.010
Why?
Socioeconomic Factors
2
1999
567
0.010
Why?
Ion Channels
1
1985
246
0.010
Why?
Defecation
1
2003
23
0.010
Why?
Fibroblast Growth Factors
1
2004
80
0.010
Why?
Surgical Stapling
1
2003
17
0.010
Why?
Stroke Volume
1
1986
456
0.010
Why?
Locomotion
1
1984
131
0.010
Why?
Animals, Newborn
1
2004
510
0.010
Why?
Intercellular Junctions
1
1983
68
0.010
Why?
Immediate-Early Proteins
1
2004
164
0.010
Why?
DNA Damage
1
2004
366
0.010
Why?
Hemodynamics
1
1986
711
0.010
Why?
Computational Biology
1
2006
528
0.010
Why?
CHO Cells
1
2002
187
0.010
Why?
Pedigree
1
2004
966
0.010
Why?
Leukocyte Count
2
1999
220
0.010
Why?
Neoplasms, Multiple Primary
1
1982
100
0.010
Why?
Glucuronides
1
2002
34
0.010
Why?
Antimetabolites, Antineoplastic
1
2003
236
0.010
Why?
Injections, Subcutaneous
1
2002
117
0.010
Why?
RNA
1
2006
560
0.010
Why?
HLA-G Antigens
1
2001
52
0.010
Why?
Uterine Rupture
1
2001
4
0.010
Why?
Trial of Labor
1
2001
5
0.010
Why?
Physicians
1
2009
674
0.010
Why?
Cognition
1
2006
571
0.010
Why?
Hospitals, Urban
1
2001
54
0.010
Why?
Carcinoma, Bronchogenic
1
1981
30
0.010
Why?
Immunologic Techniques
1
1981
27
0.010
Why?
Obstetric Labor Complications
1
2001
34
0.010
Why?
Cell Division
1
2002
696
0.010
Why?
Down-Regulation
1
2002
506
0.010
Why?
Cross-Sectional Studies
1
2006
1621
0.010
Why?
Poverty Areas
1
2001
37
0.010
Why?
Neoplasm Invasiveness
1
1982
552
0.010
Why?
Sleep, REM
1
2000
50
0.010
Why?
Medical Records
1
1981
119
0.010
Why?
Growth Hormone
1
2000
97
0.010
Why?
Tablets, Enteric-Coated
1
2000
6
0.010
Why?
Chickens
3
1985
212
0.010
Why?
Diabetes Mellitus, Type 1
1
1986
568
0.010
Why?
Diabetic Foot
1
2000
13
0.010
Why?
Placenta Accreta
1
2000
6
0.010
Why?
Polysomnography
1
2000
151
0.010
Why?
Image Processing, Computer-Assisted
1
2006
1204
0.010
Why?
Lactulose
1
2000
20
0.010
Why?
Pregnancy Complications, Parasitic
1
2000
15
0.010
Why?
Phlebitis
1
1999
1
0.010
Why?
Sterilization, Reproductive
1
2000
12
0.010
Why?
Midwestern United States
1
2000
76
0.010
Why?
Hyperglycemia
2
1994
176
0.010
Why?
Cell Transformation, Viral
2
1990
40
0.010
Why?
Colony Count, Microbial
1
1999
46
0.010
Why?
Infectious Disease Transmission, Vertical
1
2000
44
0.010
Why?
Peptic Ulcer
1
1999
19
0.010
Why?
Substance Withdrawal Syndrome
1
2000
48
0.010
Why?
Rats, Inbred Strains
3
1985
312
0.010
Why?
Emergency Treatment
1
2000
39
0.010
Why?
Respiratory Tract Diseases
1
1999
45
0.010
Why?
Lymphocyte Transfusion
1
1999
41
0.010
Why?
Eye Diseases
1
2000
53
0.010
Why?
Cicatrix
1
2000
63
0.010
Why?
Accidental Falls
1
1999
50
0.010
Why?
Procarbazine
2
1990
40
0.010
Why?
Aging
3
1993
691
0.010
Why?
Prenatal Diagnosis
1
2000
104
0.010
Why?
Liver Neoplasms
1
2005
738
0.010
Why?
Herpesvirus 4, Human
2
1990
114
0.010
Why?
Blood Cell Count
1
1999
79
0.010
Why?
Diabetic Retinopathy
1
2000
87
0.010
Why?
Hydrocortisone
1
2000
298
0.010
Why?
Abatacept
1
1998
83
0.010
Why?
Reoperation
1
2001
597
0.010
Why?
Cardiovascular Diseases
2
1999
827
0.010
Why?
Child Nutritional Physiological Phenomena
1
1998
12
0.010
Why?
Homeostasis
1
2000
409
0.010
Why?
Radius
1
1998
29
0.010
Why?
Gastrointestinal Agents
1
2000
161
0.010
Why?
CTLA-4 Antigen
1
1998
135
0.010
Why?
Intraoperative Complications
1
2000
185
0.010
Why?
Diabetes Complications
1
1999
207
0.010
Why?
Mental Health
1
1999
162
0.010
Why?
Guideline Adherence
1
2000
224
0.010
Why?
Puberty
1
1998
59
0.010
Why?
Nephrosis, Lipoid
1
1997
6
0.010
Why?
Nutritional Status
1
1998
83
0.010
Why?
Cold Temperature
1
1998
157
0.010
Why?
Glomerulosclerosis, Focal Segmental
1
1997
38
0.010
Why?
Hormones
1
1998
141
0.010
Why?
Calcium
2
1998
1156
0.010
Why?
Sensitivity and Specificity
1
2002
1992
0.010
Why?
Antigens, Plant
1
1997
14
0.010
Why?
Floors and Floorcoverings
1
1997
7
0.010
Why?
Age Distribution
1
1997
204
0.010
Why?
Lubrication
1
1997
2
0.010
Why?
Cystoscopes
1
1997
2
0.010
Why?
Dosage Forms
1
1997
7
0.010
Why?
Genetic Variation
1
2004
1351
0.010
Why?
Hospital Charges
1
1997
29
0.010
Why?
Chi-Square Distribution
1
1997
364
0.010
Why?
Antigens, CD
1
1998
458
0.010
Why?
Diet
1
2000
443
0.010
Why?
Physicians, Family
1
1997
40
0.010
Why?
Infusions, Parenteral
2
1986
50
0.010
Why?
Longitudinal Studies
1
1999
1019
0.010
Why?
Health Services Needs and Demand
1
1997
102
0.010
Why?
Health Care Surveys
1
1997
278
0.010
Why?
Uterine Neoplasms
1
2000
227
0.010
Why?
Bacteria
1
1999
447
0.010
Why?
Diagnosis, Differential
1
2000
1566
0.010
Why?
Ambulatory Care
1
1997
181
0.010
Why?
Illinois
1
1997
462
0.010
Why?
Sheep
2
1985
239
0.010
Why?
Residence Characteristics
1
1997
197
0.010
Why?
Glucose Tolerance Test
1
1995
228
0.010
Why?
Rana pipiens
2
1985
11
0.010
Why?
Amylases
1
1994
13
0.010
Why?
Kinetics
2
1988
1513
0.010
Why?
Cell Separation
1
1994
196
0.010
Why?
Cadaver
1
1994
185
0.010
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
1994
57
0.010
Why?
Mice, SCID
1
1994
252
0.010
Why?
Homozygote
1
1994
200
0.010
Why?
Marriage
1
1993
26
0.010
Why?
Rats
3
1985
3992
0.010
Why?
Rabbits
2
1985
636
0.010
Why?
Nucleotides
1
1993
95
0.010
Why?
Fertility
1
1993
115
0.010
Why?
Radioimmunoassay
1
1992
155
0.010
Why?
Autoantigens
1
1993
127
0.010
Why?
Glaucoma
1
1992
30
0.010
Why?
Islets of Langerhans Transplantation
1
1994
225
0.010
Why?
Liver
2
1988
1230
0.010
Why?
Agent Orange
1
1990
1
0.010
Why?
2,4,5-Trichlorophenoxyacetic Acid
1
1990
1
0.010
Why?
2,4-Dichlorophenoxyacetic Acid
1
1990
2
0.010
Why?
Polychlorinated Dibenzodioxins
1
1990
3
0.010
Why?
Vietnam
1
1990
14
0.010
Why?
Aerospace Medicine
1
1990
14
0.010
Why?
Physical Examination
1
1990
149
0.010
Why?
Mitomycins
1
1989
13
0.010
Why?
Methylnitronitrosoguanidine
1
1989
16
0.010
Why?
Mitomycin
1
1989
29
0.010
Why?
Skin Diseases
1
1990
166
0.010
Why?
Heart Ventricles
2
1985
760
0.010
Why?
Liver Diseases
1
1990
241
0.010
Why?
Mechlorethamine
1
1988
11
0.010
Why?
Radiation Genetics
1
1988
7
0.010
Why?
Vinblastine
1
1988
108
0.010
Why?
Cobalt Radioisotopes
1
1988
19
0.000
Why?
Environmental Exposure
1
1990
296
0.000
Why?
Bleomycin
1
1988
98
0.000
Why?
Neutrons
1
1988
58
0.000
Why?
Gamma Rays
1
1988
72
0.000
Why?
Dacarbazine
1
1988
102
0.000
Why?
Histocytochemistry
1
1987
130
0.000
Why?
Membrane Proteins
1
1994
1196
0.000
Why?
Immunoenzyme Techniques
1
1987
303
0.000
Why?
X-Rays
1
1986
130
0.000
Why?
Femoral Artery
1
1986
81
0.000
Why?
Mathematics
1
1986
190
0.000
Why?
Amphibian Proteins
1
1985
3
0.000
Why?
Xenopus
1
1986
125
0.000
Why?
Sarcolemma
1
1985
30
0.000
Why?
Tetrodotoxin
1
1985
50
0.000
Why?
Statistics as Topic
1
1986
238
0.000
Why?
Chick Embryo
1
1985
229
0.000
Why?
Radiation Tolerance
1
1986
168
0.000
Why?
Purkinje Fibers
1
1985
27
0.000
Why?
B-Lymphocytes
1
1990
724
0.000
Why?
Braces
1
1984
13
0.000
Why?
Embryo, Nonmammalian
1
1986
193
0.000
Why?
Prednisolone
1
1984
41
0.000
Why?
Tendons
1
1984
44
0.000